# Roel Funke

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/roel-funke/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,891 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 28 |
| i10-index | 39 |
| Last Known Institution | IGM Biosciences (United States) |
| OpenAlex ID | https://openalex.org/A5111904241 |
| Works | 66 |

## Researcher papers

- [Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)](https://scholariq.org/papers/differential-regulation-of-pd-l1-expression-by-immune-and-tumor-cells-in-nsclc/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [IGM Biosciences (United States)](https://scholariq.org/institutions/igm-biosciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.